Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Sell

Debt to Equity Rating

Buy

Price to Earnings Rating

Strong Buy

Analyst Rating

Buy

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

BIOMERICA INC (BMRA)

In Vitro & In Vivo Diagnostic Substances

https://www.biomerica.com

Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Europe market.

17571 VON KARMAN AVENUE
IRVINE, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

01/01/1970

Market Cap

5,382,912

Shares Outstanding

16,820,000

Weighted SO

16,821,646

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

SRDX --.--%

MOVE --.--%

AIMD --.--%

INVO --.--%

TIVC --.--%

BBLG --.--%

TNON --.--%

MOTS --.--%

MODD --.--%

Beta

-1.0850

Last Div

0.0000

Range

0.24-2.13

Chg

0.0090

Avg Vol

66990

Mkt Cap

5382912

Exch

NASDAQ

Country

US

Phone

949 645 2111

DCF Diff

1.4120

DCF

4.3120

Div Yield

0.0000

P/S

0.9959

EV Multiple

-0.1466

P/FV

0.6894

Div Yield %

0.0000

P/E

-0.8478

PEG

-0.0525

Payout

0.0000

Current Ratio

4.4430

Quick Ratio

3.3737

Cash Ratio

2.6715

DSO

76.3061

DIO

162.2849

Op Cycle

238.5909

DPO

67.4599

CCC

171.1310

Gross Margin

0.1141

Op Margin

-1.2351

Pretax Margin

-1.1658

Net Margin

-1.1746

Eff Tax Rate

-0.0076

ROA

-0.6139

ROE

-0.6400

ROCE

-0.7994

NI/EBT

1.0076

EBT/EBIT

0.9439

EBIT/Rev

-1.2351

Debt Ratio

0.0833

D/E

0.1104

LT Debt/Cap

0.0650

Total Debt/Cap

0.0994

Int Coverage

-56.2779

CF/Debt

-6.1249

Equity Multi

1.3245

Rec Turnover

4.7834

Pay Turnover

5.4106

Inv Turnover

2.2491

FA Turnover

5.3464

Asset Turnover

0.5226

OCF/Share

-0.3139

FCF/Share

-0.3201

Cash/Share

0.3162

OCF/Sales

-0.9768

FCF/OCF

1.0199

CF Coverage

-6.1249

ST Coverage

-16.5507

CapEx Coverage

-50.2157

Div&CapEx Cov

-50.2157

P/BV

0.6894

P/B

0.6894

P/S

0.9959

P/E

-0.8478

P/FCF

-0.9996

P/OCF

-1.0196

P/CF

-1.0196

PEG

-0.0525

P/S

0.9959

EV Multiple

-0.1466

P/FV

0.6894

DPS

0.0000

Latest Headlines (EST)

Benzinga Dec 19, 13:34 Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session GlobeNewswire Inc. Dec 18, 07:47 Biomerica Received US FDA 510(k) Clearance for Their Hp Detectâ„¢ ELISA Test Product Designed to Detect the Presence of the H. pylori Bacteria That infects Approximately 35% of the U.S. Population GlobeNewswire Inc. Nov 10, 08:19 Biomerica to Participate in 14th Annual Craig-Hallum Alpha Select Conference on November 16

Revenue Product Segmentation